TCM
EXAS

Traynor Capital Management’s Exact Sciences EXAS Stock Holding History

Traynor Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-85,765
Closed -$5.92M – 293
2024
Q1 		$5.92M Buy
85,765
+6,077
+8% +$384K 0.51% 35
2023
Q4 		$5.9M Buy
79,688
+11,175
+16% +$732K 0.61% 34
2023
Q3 		$4.67M Buy
68,513
+38,448
+128% +$3.26M 0.59% 36
2023
Q2 		$2.82M Buy
30,065
+4,537
+18% +$354K 0.35% 48
2023
Q1 		$1.73M Buy
25,528
+9,706
+61% +$624K 0.25% 59
2022
Q4 		$783K Buy
+15,822
New +$646K 0.11% 100
2018
Q4 		– Sell
-3,975
Closed -$313K – 171
2018
Q3 		$313K Hold
3,975
– – 0.1% 127
2018
Q2 		$240K Buy
+3,975
New +$214K 0.09% 147

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Traynor Capital Management's EXAS Position: Q2 2024 in Review

Traynor Capital Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 85,765 shares — an estimated $5.92M sold.

Traynor Capital Management first reported a position in EXAS in Q2 2018 and held it in 8 quarters. The position peaked at $5.92M in Q1 2024. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Traynor Capital Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Traynor Capital Management sold 85,765 Exact Sciences shares in Q2 2024, an estimated $5.92M.
  • Traynor Capital Management first reported a position in Exact Sciences in Q2 2018 and held it in 8 quarters.
  • Traynor Capital Management's Exact Sciences position peaked at $5.92M in Q1 2024.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Traynor Capital Management's 13F filing for Q2 2024, filed 24 Jul 2024.